Lantheus Holdings (LNTH) Acquisitions (2025 - 2026)

Lantheus Holdings (LNTH) posted quarterly Acquisitions of $37.8 million for Q4 2025, up 23009.09% quarter-over-quarter from -$165000.0 in Q3 2025.

Lantheus Holdings (LNTH) Acquisitions (2025 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has reported Acquisitions for 1 consecutive years, with $37.8 million the latest figure, recorded in Q4 2025.

In Q4 2025, Acquisitions changed N/A year-over-year to $37.8 million; the TTM figure through Mar 2026 stood at $256.7 million (up 413.47% YoY), while the FY2025 annual figure was $306.7 million, changed N/A from the prior year.
Acquisitions rose to $37.8 million in Q4 2025 per LNTH's latest filing, from -$165000.0 in the prior quarter.
Across five years, Acquisitions topped out at $219.1 million in Q2 2025 and bottomed at -$165000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Lantheus Holdings	6.54 Bn	5.94 Bn	241.86 Mn	-312,000.00

Download Data